NIGHTHAWK BIOSCIENCES, INC.
Microfluidics-enabled continuous low-energy electron irradiation (LEEI) system for terminal sterilization of pharmaceutical products
- Sector
- Biotech
- Headquarters
- Morrisville, NC
- Total capital
- $973K
- Federal grants
- $973K
- 3 awards · 2022–2023
- Rank in peer group#11 of 12
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 9 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · An IGF-1R-targeting peptide drug conjugate for targeted treatment of atypical teratoid/rhabdoid tumors$399K
- Federal grantHealth and Human S · Phase I · A next generation cross-serotype binding antitoxin for treatment of post-exposure botulinum poisoning$299K
- Federal grantHealth and Human S · Phase I · Microfluidic technology platform as a continuous end-line process to inactivate pharmaceuticals$275K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 12 peers
Line = medianBiotech · System
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 9- PendingCellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseUSPTOApplication 18725238
- PendingCellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseUSPTOApplication PCTUS2023060038
- PendingBifunctional Anti-pathogenic AgentsUSPTOApplication PCTUS2022078127
Show all 9 patent records
- Cellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseMar 13, 2025 · Application 18725238Pending
- Cellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseApplication PCTUS2023060038Pending
- Bifunctional Anti-pathogenic AgentsApplication PCTUS2022078127Pending
- Cellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseApplication 63394135Pending
- Bifunctional Anti-pathogenic AgentsApplication 63316189Pending
- System Of Cell DeactivationApplication 63315300Pending
- Microfluidics Enabled Sterilization of Complex Drug Products as Continuous End-Line ProcessApplication 63303157Pending
- Cellular Uptake Peptide-therapeutic Payload Compositions And Methods Of UseApplication 63295978Pending
- Bifunctional Anti-pathogenic AgentsApplication 63255739Pending
Related companies, and why
- INTRA THERAPEUTICS, LLCSimilar federal contract value in Biotech · null in contracts
- EXOTECT, LLCSimilar federal contract value in Biotech · null in contracts
- TARGESON, INC.Similar federal contract value in Biotech · null in contracts
- COEURATIVE, INC.Similar federal contract value in Biotech · null in contracts
- Petri Bio LLCSimilar federal contract value in Biotech · null in contracts
- Oncorus, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .